Pliant Therapeutics Statistics Share Statistics Pliant Therapeutics has 61.39M
shares outstanding. The number of shares has increased by 0.96%
in one year.
Shares Outstanding 61.39M Shares Change (YoY) 0.96% Shares Change (QoQ) 0.24% Owned by Institutions (%) 93.6% Shares Floating 51.49M Failed to Deliver (FTD) Shares 699,991 FTD / Avg. Volume 60.94%
Short Selling Information The latest short interest is 3.74M, so 6.09% of the outstanding
shares have been sold short.
Short Interest 3.74M Short % of Shares Out 6.09% Short % of Float 6.24% Short Ratio (days to cover) 4.75
Valuation Ratios The PE ratio is -3.79 and the forward
PE ratio is -0.77.
Pliant Therapeutics's PEG ratio is
-0.14.
PE Ratio -3.79 Forward PE -0.77 PS Ratio 0 Forward PS 43.5 PB Ratio 2.62 P/FCF Ratio -5 PEG Ratio -0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pliant Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.91,
with a Debt / Equity ratio of 0.2.
Current Ratio 10.91 Quick Ratio 10.91 Debt / Equity 0.2 Debt / EBITDA -0.26 Debt / FCF -0.38 Interest Coverage -75.52
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.23M Employee Count 171 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -86.56% in the
last 52 weeks. The beta is 1.44, so Pliant Therapeutics's
price volatility has been higher than the market average.
Beta 1.44 52-Week Price Change -86.56% 50-Day Moving Average 1.58 200-Day Moving Average 3.83 Relative Strength Index (RSI) 47.95 Average Volume (20 Days) 1,148,614
Income Statement
Revenue n/a Gross Profit -2.13M Operating Income -228.37M Net Income -210.3M EBITDA -228.37M EBIT -189.22M Earnings Per Share (EPS) -3.47
Full Income Statement Balance Sheet The company has 71.19M in cash and 60.19M in
debt, giving a net cash position of 11M.
Cash & Cash Equivalents 71.19M Total Debt 60.19M Net Cash 11M Retained Earnings -710.05M Total Assets 299.82M Working Capital 246.85M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -155.5M
and capital expenditures -3.85M, giving a free cash flow of -159.35M.
Operating Cash Flow -155.5M Capital Expenditures -3.85M Free Cash Flow -159.35M FCF Per Share -2.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
